Pharma Sludge Dewatering Centrifuge

Lishui Yuanrong Environmental Protection Equipment Co., Ltd. provides high‑efficiency Pharma sludge dewatering centrifuges designed for continuous, high‑capacity solid‑liquid separation. Our Pharma sludge dewatering centrifuges combine advanced centrifugal sedimentation technology with targeted designs for different material requirements in the pharmaceutical industry, efficiently reducing sludge volume and enabling solid‑liquid separation of pharmaceutical intermediates and crystals.

In the demanding fields of wastewater treatment and pharmaceutical production, equipment efficiency directly determines operating costs. Our Pharma sludge dewatering centrifuges feature targeted structural designs for pharmaceutical materials with different specific gravities, greatly improving separation performance for a wide variety of material types. 

By generating high centrifugal forces up to several thousand times gravity, they achieve extremely high solids dryness and clear liquid discharge, ensuring both separation efficiency and treatment performance.

The core of the Pharma sludge dewatering centrifuge consists of a high‑speed rotating bowl, a precision screw conveyor, and a high‑torque differential gearbox. Unlike standard models, Yuanrong has developed a unique screw structure that solves the problems of "material slippage", clogging, and achieving high solids dryness. This makes it especially suitable for pharmaceutical production where high dryness and thorough solid‑liquid separation are required, ensuring stable, uninterrupted discharge 24 hours a day. Our common‑bus dual‑inverter drive system allows seamless adjustment of bowl speed and differential speed, maintaining optimal separation performance even when feed solids concentration fluctuates.

The Pharma sludge dewatering centrifuge demonstrates excellent technical performance and application value in pharmaceutical industry sludge dewatering as well as solid‑liquid separation of raw materials. Based on the centrifugal sedimentation principle, the equipment achieves efficient separation of solid and liquid phases through differential rotation between the bowl and the screw conveyor, offering significant advantages such as high throughput, high separation factor, and a high degree of automation.

In sludge dewatering applications, the equipment can reduce the moisture content of pharmaceutical biochemical sludge from above 98% down to 75%–85%, greatly reducing sludge volume and lowering subsequent disposal costs. Its enclosed design effectively prevents the escape of volatile organic compounds and meets GMP clean production requirements. For activated sludge generated from fermentation‑based pharmaceutical wastewater (e.g., antibiotics, vitamins), the equipment, through optimized differential speed control and flocculant dosing systems, can increase sludge dryness by 10%–15%, with separation efficiency more than 40% higher than traditional plate‑and‑frame filter presses.

In raw material solid‑liquid separation, the Pharma sludge dewatering centrifuge can precisely separate herb residues from traditional Chinese medicine extracts, bacterial proteins from biological fermentation broths, and solid particles from crystal mother liquors. By adjusting the bowl speed (1500–4500 rpm) and liquid pool depth, it can flexibly adapt to different material characteristics, achieving a solid phase moisture content ≤5% and a liquid phase clarity ≥99.5%. The equipment is made of full stainless steel (316L/2205) with a mirror‑polished internal surface, meeting FDA certification standards and effectively preventing material contamination and cross‑infection.

In terms of technical innovation, the next‑generation Pharma sludge dewatering centrifuge integrates a PLC intelligent control system that monitors separation performance in real time and automatically adjusts operating parameters. The dual‑motor variable frequency drive technology enables stepless differential speed adjustment to suit different operating conditions. The patented screw conveyor design reduces material residue and improves treatment efficiency. This technical solution has been widely used in biopharmaceuticals, chemical synthetic drugs, traditional Chinese medicine preparations, and other fields, providing reliable equipment support for pharmaceutical companies to achieve clean production, improve quality, and increase efficiency.